VivaZome Therapeutics is pleased to announce that three posters highlighting the company’s strategies and technologies for exosome purification, customisation and manufacturing of extracellular vesicles (“EVs) are being presented at the 6th annual meeting of the Australian and New Zealand Society of Extracellular Vesicles (“ANZSEV”) this week in the Barossa Valley, South Australia.
Dr David Haylock, CSO of VivaZome, said: “We are delighted to be presenting this work at the ANZSEV meeting as we strive to develop new customised EV-based approaches to treat retinal disease and traumatic brain injury with our esteemed collaborators at Australian National University, The University of Queensland, Cytiva and SeerPharma. These posters highlight the strong progress we are making.” For the full release, please click here.
To view the poster, “From Laboratory to Manufacturing; Methods and Challenges in Exosome Purification” (Shambrook et al) click here.
For the poster, “Customisation strategies and loading of EVs to treat neurological disease” (Johnston et al), please click here.
For the poster, ”Establishing a robust exosome manufacturing process for translational studies” (Krishna et al), click here.
